Exchange: NASDAQ·Updated 01:04 PM EDT
ACB logo

ACBAurora Cannabis Inc

$2.69
$0.01
(0.37%)
Today
EarningsAug 5
Mkt Cap$166M
Vol504,241.00
News
all
press releases
ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?
Aurora Cannabis' shares plunge 28% in three months as a cautious fiscal 2027 outlook overshadows record medical cannabis growth and global expansion.
Zacks
More News
Aurora Named to TIME Canada's Best Companies 2026 List
Aurora Named to TIME Canada's Best Companies 2026 List Aurora Named to TIME Canada's Best Companies 2026 List PR Newswire EDMONTON, AB, July 9, 2026 NASDAQ | TSX: ACBThe Company makes history as the first and only cannabis company to ever receive this recognitionEDMONTON, AB, July 9, 2026...
PR Newswire
VFF Stock Loses 27% in Three Months: Time to Invest or Exit?
Village Farms has slid 27% in three months despite strong international cannabis growth. Can European expansion outweigh rising competition and pricing risks?
Zacks
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General Meeting of...
PR Newswire
TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell?
Tilray expands its medical cannabis strategy with HelloMD, adding virtual patient access as investors weigh growth potential against ongoing profitability challenges.
Zacks
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?
Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.
Zacks
Aurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs
ACB frames fiscal 2027 as a reset year as Canadian reimbursement pressure weighs on margins, even as global medical cannabis growth continues.
Zacks
Aurora Cannabis Q4 2026 Earnings Call Transcript
read more...
Benzinga
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA PR Newswire EDMONTON, AB, June 11, 2026 NASDAQ | TSX...
PR Newswire
TLRY Stock Back Into The Limelight – A Look At The Key Developments That Sparked Investor Optimism
Tilray stock was in focus after a recent government effort to reclassify Hemp and the upcoming DEA hearing about marijuana.
Stocktwits
<
1
2
...
>

Advertisement|Remove ads.